CVS Group earnings 'in line' with guidance as it awaits CMA outcome
CVS Group (AIM:CVSG) reported adjusted EBITDA of approximately £134 million for the year ended 30 June 2025, in line with market consensus, according to a trading update released on Thursday. The veterinary services provider said revenue from continuing operations rose 5.4% to £673.2 million, with like-for-like sales up 0.2%.
TotalEnergies, CMA CGM launch LNG bunkering logistics JV in Rotterdam
TotalEnergies and French shipping group CMA CGM have launched a joint venture to operate a liquefied natural gas (LNG) bunker supply solution at the Dutch port of Rotterdam, the French oil major said on Wednesday.
Comerica: Solid Q2, But Structural Concerns Remain (Downgrade)
Comerica's recent rally appears overdone; fundamentals do not justify the current valuation, and I now rate shares a 'sell.' Deposit costs are rising and deposit outflows persist, with further pressure expected as the Direct Express contract winds down. Loan growth is modest, and while credit quality and capital remain solid, net interest margin faces ongoing headwinds.
Comerica Q2 Earnings Top Estimates on Strength in NII & Loan Growth
CMA tops Q2 earnings estimates as NII jumps nearly 8% and loan balances climb, despite asset quality concerns.
Comerica Incorporated (CMA) Q2 2025 Earnings Call Transcript
Comerica Incorporated (NYSE:CMA ) Q2 2025 Earnings Conference Call July 18, 2025 8:00 AM ET Company Participants R - Corporate Participant e - Corporate Participant g - Corporate Participant s - Corporate Participant e - Corporate Participant Curtis Chatman Farmer - Chairman, CEO & President James J. Herzog - CFO & Senior EVP Kelly Gage - Senior VP & Director of Investor Relations Melinda A.
Comerica (CMA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Comerica (CMA) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Comerica Incorporated (CMA) Q2 Earnings and Revenues Beat Estimates
Comerica Incorporated (CMA) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $1.53 per share a year ago.
Comerica's Q2 Earnings to be Hurt by Higher Expenses & Lower Deposits
CMA's Q2 earnings may fall 19.6% despite revenue gains, as rising expenses and deposit declines weigh on results.
Seeking Clues to Comerica (CMA) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Comerica (CMA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
CMA: Well-Managed, But Waiting For A Clear Trigger
I assign Comerica a hold rating, reflecting a balance between solid fundamentals and short-term risks constraining its outlook. Comerica's disciplined cost management supports stable margins and profitability, even as revenues face pressure from a challenging macro environment. Valuation appears fair, with no clear over or undervaluation, and my conservative DCF suggests limited upside under very conservative assumptions.
Comerica Incorporated (CMA) Expected to Beat Earnings Estimates: Should You Buy?
Comerica (CMA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Housebuilders shell out 'peanuts' in settlement to end CMA legal investigation
The offer by seven of the UK's largest housebuilders to pay £100 million and agree to legally binding restrictions on sharing information with purported rivals to resolve a competition investigation was a "get out of jail free card", one analyst said. Coming on the same day that Sir Brian Leveson published a report with various recommendations to help clear Britain's legal backlog, including calling for more out-of-court settlements, the housebuilders made a similar offer to the Competition and Markets Authority to avoid taking an ongoing investigation further.
